Balyasny Asset Management
KALV icon

Balyasny Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Balyasny Asset Management’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,968
Closed -$312K – 2157
2024
Q3 		$312K Buy
+26,968
New +$312K ﹤0.01% 1694
2024
Q1 		– Sell
-11,905
Closed -$146K – 2215
2023
Q4 		$146K Buy
11,905
+1,235
+12% +$15.1K ﹤0.01% 1784
2023
Q3 		$103K Buy
+10,670
New +$103K ﹤0.01% 1645